相关实验视频

Updated: Jan 15, 2026

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

在PROTAC中,新基质降解的双刃剑

Zihan Song¹, Chengze Duan¹, Mingfei Wu¹

¹School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang, China.

European journal of medicinal chemistry

|October 10, 2025

概括

免疫调节药物 (IMiDs) 是开发蛋白质分解向仿真体 (PROTACs) 的关键. 本综述探讨了利用协同效应和减轻非目标降解,以改善基于CRBN的PROTAC疗法.

科学领域:

* 生物化学和分子生物学
* 医学化学医学化学
* 药物发现和开发

背景情况:

*像thalidomide这样的免疫调节药物 (IMiDs) 是招募蛋白质分解向仿真体 (PROTACs) 中E3化脑蛋白 (CRBN) 的关键配体.
*基于CRBN的PROTAC可以诱导向蛋白质降解和意外的新基质降解,提供治疗机会和毒性责任.
* IMiD-PROTACs 的协同效应提供了新的治疗策略,但非目标降解需要谨慎管理.

研究的目的:

* 系统地审查利用IMID-PROTACs协同效应的进展.
* 探索在基于CRBN的PROTAC中减轻意外新基质降解的策略.
* 讨论在基于CRBN的PROTAC系统中消除或保留非目标效应的药物化学方法.

主要方法:

*对基于CRBN的PROTAC进行当前研究的综合文献综述.
* 对协同效应和新基质降解机制的分析.
*讨论用于优化PROTAC的药物化学策略.

主要成果:

* IMiD-PROTACs通过协同效应展示了创新的疾病治疗潜力.
* 基于CRBN的PROTACs的非目标降解可能导致有毒负债.
*药用化学提供了控制新基质降解的途径,根据需要消除或保存它.

结论:

*优化基于CRBN的PROTAC需要一个细微的方法来管理新基质降解.
*合理调节新基质降解可以提高治疗疗效和安全性.
* 本工作为下一代基于CRBN的PROTAC的合理设计提供了指导.

关键词:

编号:CRBN 编号:CRBN 编号:CRBN 编号:CRBN 编号:CRBN 编号:CRBN 编号:CRBN 退化退化退化退化这就是IMIDs.新基板是一种新基板.这就是 PROTACs.有协同效应的效应.

更多相关视频

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Spontaneous Formation and Rearrangement of Artificial Lipid Nanotube Networks as a Bottom-Up Model for Endoplasmic Reticulum

Spontaneous Formation and Rearrangement of Artificial Lipid Nanotube Networks as a Bottom-Up Model for Endoplasmic Reticulum

Published on: January 22, 2019

相关概念视频

Regulated Protein Degradation

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

The Proteasome

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

ATP Synthase: Mechanism

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...